Comparison of Cephalexin Versus Clindamycin for Suspected CA-MRSA Skin Infections
Staphylococcal Infection, Abscess, Staphylococcal Skin Infection
About this trial
This is an interventional treatment trial for Staphylococcal Infection focused on measuring clinical trial, randomized, blinded, controlled
Eligibility Criteria
Inclusion Criteria: Children between the ages of 6 months and 18 years of age (inclusive) Suspected purulent staphylococcal skin or soft tissue infection No hospitalization within the previous 14 days Must have reliable means of follow-up contact (e.g. working phone) Outpatient management in the judgement of treating physician Exclusion Criteria: Hospitalization on initial visit Voluntary withdrawal by the treating physician in order to dictate the antibiotic being used Patients with a history of hypersensitivity to or intolerance of cephalexin (or other beta lactams) or clindamycin. Patients with altered immunity (inherited or acquired) Patients with skin infections related to surgical wounds or hardware. Patients currently on antibiotic therapy
Sites / Locations
- Johns Hopkins University
Arms of the Study
Arm 1
Arm 2
Placebo Comparator
Active Comparator
cephalexin
clindamycin